|
Sep 30
|
Novo Nordisk (NVO) Poised for 23.3% Upside as Obesity Market Expands and Clinical Trials Impress
|
|
Sep 30
|
Is Novo Nordisk A/S (NYSE:NVO) The Top Global Stock To Buy Now?
|
|
Sep 29
|
'Stop Ripping Us Off' – Incredibly, Elon Musk And Bernie Sanders Seem To Agree On This One Thing – 'I Really Am With Bernie On This One'
|
|
Sep 28
|
15 Unhealthiest Countries in Europe
|
|
Sep 28
|
Success in This New Battleground Could Make Eli Lilly and Novo Nordisk Stock Absolutely Fly for Years
|
|
Sep 27
|
Novo Nordisk stock closes lower, analyst warns about Wegovy sales
|
|
Sep 27
|
Top Midday Stories: Bristol-Myers Squibb Gets FDA Approval for Schizophrenia Drug; Novo Nordisk Shares Drop After Analyst's Sales Concerns
|
|
Sep 27
|
PFE vs. NVO: Which Stock Is the Better Value Option?
|
|
Sep 6
|
Why Big Pharma is betting on telehealth strategies
|
|
Sep 6
|
Eli Lilly's Weekly Insulin Shot Meets Two Late-Stage Study Goals
|
|
Sep 6
|
Who Can Use the New Obesity Drugs? Nearly Half of Adults Under 65 Are Eligible.
|
|
Sep 5
|
Novo Nordisk’s Ozempic Shortage Is Worsening. That’s Good for Eli Lilly Stock.
|
|
Sep 5
|
Eli Lilly Makes Strides on Weekly Insulin Shot as Novo Nordisk Stumbles
|
|
Sep 5
|
Eli Lilly Just Made Zepbound Even More Appealing. Here's What Smart Investors Need to Know.
|
|
Sep 5
|
Lilly builds case for weekly insulin shot
|
|
Sep 4
|
How Lilly, Novo Could Beat Tesla To The Trillion-Dollar Club; Plus, Nvidia's Battle With Microsoft, Apple
|
|
Sep 4
|
High-dose Spinraza meets study goal; Top Dyne executives exit
|
|
Sep 3
|
Viking Surges 342% in the Past Year: How Should You Play the Stock?
|
|
Sep 3
|
UAE MoHAP and Novo Nordisk partner for obesity management
|
|
Aug 31
|
3 No-Brainer Stocks to Buy in September
|